Ads
related to: Renal Cell Carcinoma- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- How This Treatment Works
Search results
New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
Medical Xpress· 3 days agoA novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of ...
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis...
Medical Xpress· 4 days agoThe findings lay the groundwork to identify therapeutic targets in non-clear-cell renal cell carcinomas. Renal < ...
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients - British...
Nature· 7 days agoTregs trafficking is controlled by CXCR4. In Renal Cell Carcinoma (RCC), the effect of the new CXCR4 antagonist, R54, was explored in ...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 7 hours agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
Plasma proteome profiling reveals dynamic of cholesterol marker after dual blocker therapy - Nature...
Nature· 3 days agoDual blockade therapy is currently being trialled for multiple tumour types, but efficacy is variable. Here, the authors use longitudinal proteomics profiling of 22 patients to develop a predictive model of therapy response.
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoCytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript May 8, 2024 CytomX...
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoWe'd also like to congratulate ArsenalBio, who in April announced the first patient dosed in a Phase...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 4 days agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
Nexavar Dosage: Form, Strength, How to Take, and More
Healthline· 4 days agoNexavar (sorafenib) is a prescription drug used to treat liver, kidney, and thyroid cancers. Nexavar belongs to a group of drugs called kinase inhibitors and contains the active ingredient sorafenib ...
Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
Forbes· 5 days agoThis article is part of an ongoing series on novel cancer advances, including immunotherapies such...
